Entecavir
Common brands: Baraclude, Lasix, Dexamethasone, Dexamethasone 1.5 Mg, Dextenza
Top reporter: E.R. Squibb & Sons, L.L.C.
Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]Corticosteroid [EPC]Nonsteroidal Anti-inflammatory Drug [EPC]Kinase Inhibitor [EPC]Proton Pump Inhibitor [EPC]
11,390
Total Reports
4,798
Serious Reports
1,861
Death Reports
30
Reported Reactions
Death Report Ratio: High (16.34%)
Patient Demographics
Reported Adverse Reactions (30)
Side effects reported in FDA adverse event reports for Entecavir.
| # | Reaction | Reports | % of Total |
|---|---|---|---|
| 1 | DEATH | 544 | |
| 2 | OFF LABEL USE | 515 | |
| 3 | DRUG INEFFECTIVE | 436 | |
| 4 | DRUG RESISTANCE | 403 | |
| 5 | DIARRHOEA | 371 | |
| 6 | FATIGUE | 356 | |
| 7 | PYREXIA | 354 | |
| 8 | HEPATITIS B | 328 | |
| 9 | NAUSEA | 319 | |
| 10 | PLATELET COUNT DECREASED | 294 | |
| 11 | PNEUMONIA | 294 | |
| 12 | ANAEMIA | 231 | |
| 13 | HEPATIC FAILURE | 229 | |
| 14 | RENAL IMPAIRMENT | 225 | |
| 15 | WHITE BLOOD CELL COUNT DECREASED | 221 | |
| 16 | NEUTROPENIA | 219 | |
| 17 | ASTHENIA | 218 | |
| 18 | HEPATOCELLULAR CARCINOMA | 211 | |
| 19 | ALANINE AMINOTRANSFERASE INCREASED | 209 | |
| 20 | ACUTE KIDNEY INJURY | 204 | |
| 21 | DECREASED APPETITE | 204 | |
| 22 | THROMBOCYTOPENIA | 198 | |
| 23 | FEBRILE NEUTROPENIA | 192 | |
| 24 | HEADACHE | 189 | |
| 25 | RASH | 186 | |
| 26 | DYSPNOEA | 185 | |
| 27 | MALAISE | 177 | |
| 28 | HEPATITIS B REACTIVATION | 166 | |
| 29 | RENAL FAILURE | 162 | |
| 30 | VOMITING | 162 |
Important Disclaimer
FDA adverse event reports are submitted voluntarily and do not prove causation. A reported reaction does not mean the drug caused it. Drugs with more users naturally have more reports. Always consult your doctor or pharmacist before making medication decisions.